Clinical TrialsSearch results
Number of results: 194
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19
Other
- Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-II: Multicenter phase II clinical trial for children with non-T-ALL in intermediate risk group stratified by the minimal residual disease (MRD).
- first relapsed acute lymphoblastic leukemia in children
- Japanese Peditric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-06-01
Other
- Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-I: Prospective observational study
- first relapsed acute lymphoblastic leukemia in children
- Japanese Peditric Leukemia/Lymphoma Study Group
- 2009-06-01
Other
- Multi-Center Phase II Study on Efficacy of High-Slip Skin Care Pad for Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Renal Cell Carcinoma
- Renal cell carcinoma
- Japanese Society of Renal Cancer (JSRC)
- 2009-05-29
Other
- Biomarker-Cohort Study of Adjuvant Chemotherapy for Stage III Colon Cancer
- Colon cancer
- Tokyo Medical and Dental University
- 2009-05-29
Other
- A non-randomized confirmatory study of Limited Surgical Resection for Peripheral Early Lung Cancer Defined with Thoracic Thin-section Computed Tomography (JCOG0804/WJOG4507L)
- small (2 cm or less) peripheral radiological non-invasive lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-05-26
Other
- To evaluate the efficacy and safety of KP-496NS for patients with perennial allergic rhinitis
- Perennial allergic rhinitis
- KAKEN PHARMACEUTICAL CO., LTD.
- 2009-04-01
Other
- Study to determine diagnostic value of plasma free metanephrine and normetanephrine for the diagnosis of pheochromocytomas.
- pheochromocytomas
- Graduate School of Comprehensive Human Sciences Molecular Clinical patholgy
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)
- Advanced non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2009-03-31